Bill > S664

This bill proposes to replace the existing National Institute of Allergy and Infectious Diseases (NIAID) with three separate national research institutes: the National Institute of Allergic Diseases, the National Institute of Infectious Diseases, and the National Institute of Immunologic Diseases. The bill restructures the organization by creating distinct institutes with specific research focuses - allergic diseases, infectious diseases (including tropical diseases), and immunologic diseases, respectively. The bill also establishes new provisions for appointing directors to these institutes, including requiring presidential appointment with Senate confirmation and setting 5-year terms with the possibility of one additional term. The transition will be managed by the Director of the National Institutes of Health, who will oversee the new institutes until their specific directors are appointed. Additionally, the bill makes numerous technical amendments to existing laws to reflect this organizational change, ensuring that all previous references to NIAID will now be understood as references to the three new institutes. This restructuring aims to provide more focused and specialized research efforts in these critical medical domains.

Health and Social Services

https://www.congress.gov/bill/119th-congress/senate-bill/664/all-info